Skip to main content
66°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Theratechnologies Inc
(TSX:
TH
)
1.780
+0.050 (+2.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Theratechnologies Inc
< Previous
1
2
3
Next >
Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV
October 19, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
October 16, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
October 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA
October 04, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
September 26, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
September 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review
September 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
September 18, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights
September 05, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
August 30, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Completes 1-for-4 Reverse Stock Split
July 31, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
July 28, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn
July 21, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces 1-for-4 Reverse Stock Split
July 20, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates
July 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update
June 29, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management
June 22, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial
June 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
June 02, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
May 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports on its Annual Meeting of Shareholders
May 09, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
May 04, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Data Presentations at AACR 2023 Showcase Potential of Sudocetaxel Zendusortide as a Single Agent and in Combination with other Anticancer Therapies
April 18, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023
April 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update
April 03, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
March 14, 2023
From
Theratechnologies
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.